Emily English
Chief Executive Officer presso Gemstone Biotherapeutics LLC
Patrimonio netto: 392 $ in data 31/03/2024
Profilo
Emily P.
English is currently the Chief Executive Officer at Gemstone Biotherapeutics LLC and the Vice President-Quality Assurance at Cartesian Therapeutics, Inc. She previously worked as the Chief Executive Officer at The Johns Hopkins University.
Dr. English holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of Maryland.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
0.00% | 09/04/2024 | 603 ( 0.00% ) | 392 $ | 31/03/2024 |
Posizioni attive di Emily English
| Società | Posizione | Inizio |
|---|---|---|
Gemstone Biotherapeutics LLC
 Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Chief Executive Officer | - |
Precedenti posizioni note di Emily English
| Società | Posizione | Fine |
|---|---|---|
| The Johns Hopkins University | Chief Executive Officer | - |
Formazione di Emily English
| University of Wisconsin | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Gemstone Biotherapeutics LLC
Gemstone Biotherapeutics LLC BiotechnologyHealth Technology Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD. | Health Technology |
- Borsa valori
- Insiders
- Emily English
